Evidence map›Paper›PMID 32040709›Full record

ReviewMycopathologia2020

Re-drawing the Maps for Endemic Mycoses.

Nida Ashraf, Ryan C Kubat, Victoria Poplin, Antoine A Adenis, David W Denning, Laura Wright, Orion McCotter, Ilan S Schwartz, Brendan R Jackson, Tom Chiller and 1 more

Abstract readReview
In one paragraph

Review in Mycopathologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. The microbiome of bat guano: for what is this knowledge important?Applied microbiology and biotechnology · 2021
    Pooled it
  6. Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nida AshrafDivision of Infectious Diseases, Department of Internal Medicine, University of Kansas, Kansas City, KS, USA.
Ryan C KubatDivision of Infectious Diseases, Department of Internal Medicine, University of Kansas, Kansas City, KS, USA.
Victoria PoplinDepartment of Internal Medicine, University of Kansas, Kansas City, KS, USA.
Antoine A AdenisCentre d'Investigation Clinique Antilles-Guyane, Inserm 1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
David W DenningFaculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Laura WrightGeographic Research Analysis and Services Program, Division of Toxicology and Human Health Services, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Orion McCotterMycotic Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ilan S SchwartzDivision of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.
Brendan R JacksonMycotic Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tom ChillerMycotic Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nathan C BahrDivision of Infectious Diseases, Department of Internal Medicine, University of Kansas, Kansas City, KS, USA. nbahr@kumc.edu.ORCID http://orcid.org/0000-0002-9431-8938

Funding

Novel Diagnostic Development for TB Meningitis and HistoplasmosisK23NS110470 · NINDS · UNIVERSITY OF MINNESOTA · PI BAHR, NATHAN · 2019 to 2023
$1.0M
Medical Research Council MR/P017622/1NINDS NIH HHS K23 NS110470NINDS NIH HHS K23NS110470
6 · The paper itself

Abstract

Endemic mycoses such as histoplasmosis, coccidioidomycosis, blastomycosis, paracoccidioidomycosis, and talaromycosis are well-known causes of focal and systemic disease within specific geographic areas of known endemicity. However, over the past few decades, there have been increasingly frequent reports of infections due to endemic fungi in areas previously thought to be "non-endemic." There are numerous potential reasons for this shift such as increased use of immune suppressive medications, improved diagnostic tests, increased disease recognition, and global factors such as migration, increased travel, and climate change. Regardless of the causes, it has become evident that our previous understanding of endemic regions for these fungal diseases needs to evolve. The epidemiology of the newly described Emergomyces is incomplete; our understanding of it continues to evolve. This review will focus on the evidence underlying the established areas of endemicity for these mycoses as well as new data and reports from medical literature that support the re-thinking these geographic boundaries. Updating the endemic fungi maps would inform clinical practice and global surveillance of these diseases.

Indexed as

Endemic DiseasesBlastomycosisCoccidioidomycosisFungiHistoplasmosisHumansMycosesParacoccidioidomycosisBlastomycosisCoccidioidomycosisEmergomycesEndemic fungiHistoplasmosisParacoccidioidomycosisTalaromycosis

Identifiers

PMID32040709
PMCPMC7416457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.